THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

Annual Review of Immunology - Tập 14 Số 1 - Trang 649-681 - 1996
Albert S. Baldwin1
1Lineberger Comprehensive Cancer Center, Curriculum in Genetics and Molecular Biology, and Department of Biology, University of North Carolina, Chapel Hill, North Carolina 27599

Tóm tắt

▪ Abstract  The transcription factor NF-κB has attracted widespread attention among researchers in many fields based on the following: its unusual and rapid regulation, the wide range of genes that it controls, its central role in immunological processes, the complexity of its subunits, and its apparent involvement in several diseases. A primary level of control for NF-κB is through interactions with an inhibitor protein called IκB. Recent evidence confirms the existence of multiple forms of IκB that appear to regulate NF-κB by distinct mechanisms. NF-κB can be activated by exposure of cells to LPS or inflammatory cytokines such as TNF or IL-1, viral infection or expression of certain viral gene products, UV irradiation, B or T cell activation, and by other physiological and nonphysiological stimuli. Activation of NF-κB to move into the nucleus is controlled by the targeted phosphorylation and subsequent degradation of IκB. Exciting new research has elaborated several important and unexpected findings that explain mechanisms involved in the activation of NF-κB. In the nucleus, NF-κB dimers bind to target DNA elements and activate transcription of genes encoding proteins involved with immune or inflammation responses and with cell growth control. Recent data provide evidence that NF-κB is constitutively active in several cell types, potentially playing unexpected roles in regulation of gene expression. In addition to advances in describing the mechanisms of NF-κB activation, excitement in NF-κB research has been generated by the first report of a crystal structure for one form of NF-κB, the first gene knockout studies for different forms of NF-κB and of IκB, and the implications for therapies of diseases thought to involve the inappropriate activation of NF-κB.

Từ khóa


Tài liệu tham khảo

10.1016/0092-8674(86)90346-6

10.1016/0092-8674(86)90807-X

10.1126/science.3140380

10.1146/annurev.iy.12.040194.001041

10.1146/annurev.cb.10.110194.002201

10.1016/0955-0674(93)90014-H

10.1016/S0074-7696(08)61873-2

10.1016/S0168-9525(00)89045-9

10.1101/gad.7.11.2064

10.1016/0168-9525(93)90106-R

10.1016/S0065-230X(08)60257-2

10.1016/1074-7613(95)90112-4

10.1128/MCB.14.12.8460

10.1128/MCB.15.6.3100

Parry G, 1994, J. Biol. Chem., 269, 20,823, 10.1016/S0021-9258(17)31895-1

10.1016/0092-8674(91)90022-Q

10.1126/science.1891714

10.1002/j.1460-2075.1994.tb06782.x

10.1002/j.1460-2075.1994.tb06723.x

10.1128/MCB.15.2.872

10.1002/j.1460-2075.1993.tb05939.x

10.1128/MCB.15.4.2166

Dobrzanski P, 1995, Oncogene, 10, 1003

10.1073/pnas.91.26.12634

10.1128/MCB.14.6.3915

10.1016/0092-8674(95)90511-1

10.1074/jbc.270.18.10680

10.1093/hmg/3.5.793

10.1038/373303a0

10.1038/373311a0

Schmid R, 1994, J. Biol. Chem., 269, 32,162, 10.1016/S0021-9258(18)31615-6

10.1016/0092-8674(94)90126-0

10.1074/jbc.270.8.4138

10.1016/0092-8674(92)90595-4

10.1016/0092-8674(93)90495-C

10.1016/0092-8674(92)90596-5

10.1101/gad.9.7.783

10.1128/MCB.13.10.6147

Wu RL, 1994, J. Biol. Chem., 269, 28,450, 10.1016/S0021-9258(18)46948-7

Lawrence R, 1994, J. Biol. Chem., 269, 28,913, 10.1016/S0021-9258(19)61994-0

10.1101/gad.8.6.678

10.1128/MCB.14.8.5349

10.1128/MCB.14.5.3276

10.1084/jem.181.3.1169

10.1074/jbc.270.21.12343

Berberich I, 1994, J. Immunol., 153, 4357, 10.4049/jimmunol.153.10.4357

Sen J, 1995, J. Immunol., 154, 3213, 10.4049/jimmunol.154.7.3213

10.1016/0896-6273(89)90266-3

10.1002/j.1460-2075.1993.tb06110.x

10.1073/pnas.91.1.390

10.1128/MCB.14.6.3981

10.1074/jbc.270.8.3710

10.1128/MCB.13.3.1572

10.1128/MCB.14.11.7226

10.1074/jbc.270.26.15576

10.1074/jbc.270.13.7219

10.1038/352733a0

10.1074/jbc.270.7.3123

10.1074/jbc.270.19.11453

10.1128/MCB.14.10.6635

10.1128/MCB.14.10.6570

10.1074/jbc.270.15.8976

10.1128/MCB.15.5.2558

10.1128/MCB.14.10.6464

10.1128/MCB.14.9.5701

10.1074/jbc.270.2.933

10.1073/pnas.92.8.3561

10.1128/MCB.15.3.1786

10.1128/MCB.15.1.152

10.1016/0092-8674(95)90506-5

10.1084/jem.181.4.1459

10.1128/MCB.14.5.2926

10.1074/jbc.270.29.17064

Zie QW, 1994, J. Biol. Chem., 269, 4705, 10.1016/S0021-9258(17)37600-7

10.1002/j.1460-2075.1994.tb06329.x

10.1073/pnas.90.5.1696

10.1128/MCB.13.11.7191

Wechler A, 1994, J. Immunol., 153, 2515, 10.4049/jimmunol.153.6.2515

10.1182/blood.V83.9.2469.2469

10.1128/MCB.14.2.1039

10.1128/MCB.14.12.7967

Wu H, 1994, J. Biol. Chem., 269, 20,067, 10.1016/S0021-9258(17)32128-2

10.1016/0092-8674(95)90415-8

10.1084/jem.181.1.181

10.1016/0092-8674(95)90416-6

10.1038/373531a0

10.1038/376167a0

10.1101/gad.9.16.1965

10.1101/gad.9.22.2736

10.1128/MCB.14.11.7377

10.1002/j.1460-2075.1994.tb06878.x

10.1073/pnas.91.25.11884

10.1073/pnas.91.26.12740

10.1073/pnas.92.2.552

10.1128/MCB.15.3.1302

10.1128/MCB.15.3.1294

10.1016/S0092-8674(94)90482-0

10.1126/science.7878466

10.1128/MCB.15.5.2809

10.1002/j.1460-2075.1995.tb07287.x

10.1101/gad.9.13.1586

10.1073/pnas.92.24.11259

10.1073/pnas.92.17.7637

10.1128/MCB.15.5.2413

10.1128/MCB.15.10.5339

10.1002/j.1460-2075.1994.tb06781.x

10.1016/0378-1119(95)00507-3

10.1074/jbc.270.6.2703

10.1128/MCB.15.3.1737

10.1128/MCB.15.5.2689

10.1016/0092-8674(95)90435-2

10.1073/pnas.91.14.6288

10.1126/science.7914032

10.1073/pnas.90.20.9247

Finco T, 1993, J. Biol. Chem., 268, 17, 10.1016/S0021-9258(17)46756-1

10.1002/j.1460-2075.1994.tb06578.x

Hayashi T, 1993, J. Biol. Chem., 268, 26,790, 10.1016/S0021-9258(19)74382-8

10.1084/jem.181.3.1091

10.1074/jbc.270.31.18347

10.1016/0092-8674(94)90275-5

Machleidt T, 1994, J. Biol. Chem., 269, 13,760, 10.1016/S0021-9258(17)36712-1

10.1093/intimm/6.8.1269

Johns L, 1994, J. Immunol., 152, 5877, 10.4049/jimmunol.152.12.5877

10.1074/jbc.270.39.22689

10.1016/1074-5521(95)90076-4

Brennan P, 1995, Biochem. Biophys. Acta, 1260, 1670

10.1006/bbrc.1995.1693

10.1016/S0969-2126(01)00159-9

10.1016/0165-2478(95)00213-O

Koong A, 1994, Cancer Res., 54, 1425

Koong A, 1994, Cancer Res., 54, 5273

10.1073/pnas.92.5.1480

10.1006/viro.1995.1029

Sukuki T, 1995, Oncogene, 10, 1199

10.1074/jbc.270.20.11745

10.1128/MCB.14.10.6443

Suzuki T, 1994, Oncogene, 9, 3099

10.1182/blood.V84.9.2904.2904

10.1084/jem.179.3.961

10.1002/j.1460-2075.1995.tb07030.x

10.1002/j.1460-2075.1995.tb07141.x

10.1016/1074-7613(94)90068-X

Niederman T, 1992, J. Virol., 66, 6213, 10.1128/jvi.66.10.6213-6219.1992

Herrero J, 1995, J. Virol., 69, 2168, 10.1128/jvi.69.4.2168-2174.1995

Mitchell T, 1995, J. Virol., 69, 2968, 10.1128/jvi.69.5.2968-2976.1995

Paine E, 1995, J. Virol., 69, 4572, 10.1128/jvi.69.7.4572-4576.1995

Huen D, 1995, Oncogene, 10, 549

10.1016/0092-8674(95)90489-1

10.1016/0092-8674(95)90070-5

10.1002/jcb.240570214

10.1074/jbc.270.16.9558

10.1016/0092-8674(93)80068-P

10.1073/pnas.91.2.752

Mukaida N, 1994, J. Biol. Chem., 269, 13,289, 10.1016/S0021-9258(17)36831-X

10.1128/MCB.15.2.943

10.1210/me.9.4.401

10.1126/science.270.5234.283

10.1126/science.270.5234.286

10.1126/science.8052854

Lai JH, 1994, J. Biol. Chem., 269, 30

10.1161/01.RES.76.6.980

10.1074/jbc.270.23.14214

Lander H, 1993, J. Immunol., 150, 1509, 10.4049/jimmunol.150.4.1509

10.1084/jem.179.3.931

10.1002/j.1460-2075.1995.tb07191.x

10.1016/0014-5793(95)00157-5

10.1016/0092-8674(95)90085-3

10.1016/0092-8674(93)90134-C

10.1016/0092-8674(94)90131-7

Pahl H, 1995, J. Virol., 69, 1480, 10.1128/jvi.69.3.1480-1484.1995

10.1161/01.CIR.91.9.2488

10.1172/JCI117409

10.1006/bbrc.1994.2552

Beauparlant P, 1994, Oncogene, 9, 3189

10.1126/science.1299224

Zhang J, Oncogene, 9, 1931

Thakur S, 1994, Oncogene, 9, 2335

Hwang S, 1995, Cancer Biochem. Biophys., 14, 265

10.1126/science.7777860

10.1126/science.7792600